Vertex Pharmaceuticals Incorporated shares owned by Skandinaviska Enskilda Banken AB
Quarter-by-quarter ownership of Vertex Pharmaceuticals Incorporated (VRTX) shares owned by Skandinaviska Enskilda Banken AB
from 13F filings
Historical chart of Skandinaviska Enskilda Banken AB investment in Vertex Pharmaceuticals Incorporated
Tip: Access up to 7 years of quarterly data
All positions including Vertex Pharmaceuticals Incorporated held by Skandinaviska Enskilda Banken AB consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Vertex Pharmaceuticals Incorporated by Skandinaviska Enskilda Banken AB
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $60M | 154k | 391.53 |
| 2025-06-30 | $79M | 177k | 445.33 |
| 2025-03-31 | $90M | 187k | 484.56 |
| 2024-12-31 | $68M | 171k | 399.35 |
| 2024-09-30 | $86M | 185k | 465.20 |
| 2024-03-31 | $111M | 265k | 418.31 |
| 2023-09-30 | $114M | 327k | 347.83 |
| 2023-06-30 | $133M | 377k | 352.67 |
| 2023-03-31 | $140M | 444k | 315.55 |
| 2022-12-31 | $117M | 407k | 288.78 |
| 2022-09-30 | $102M | 352k | 289.54 |
| 2022-06-30 | $71M | 253k | 281.79 |
| 2022-03-31 | $61M | 232k | 260.97 |
| 2021-12-31 | $64M | 288k | 222.45 |
| 2021-09-30 | $54M | 298k | 181.35 |
| 2021-06-30 | $62M | 307k | 202.27 |
| 2021-03-31 | $74M | 345k | 213.64 |
| 2020-12-31 | $63M | 266k | 236.34 |
| 2020-09-30 | $73M | 269k | 272.12 |
| 2020-06-30 | $81M | 279k | 290.31 |
| 2020-03-31 | $41M | 173k | 237.95 |
| 2019-12-31 | $25M | 115k | 218.95 |
| 2019-09-30 | $19M | 112k | 169.42 |
| 2019-06-30 | $18M | 98k | 183.38 |
| 2019-03-31 | $20M | 106k | 183.95 |
| 2018-12-31 | $14M | 83k | 165.71 |
| 2018-09-30 | $15M | 80k | 192.74 |
| 2018-06-30 | $13M | 79k | 169.96 |
| 2018-03-31 | $11M | 68k | 162.98 |
| 2017-12-31 | $12M | 79k | 149.86 |
| 2017-09-30 | $14M | 94k | 152.04 |
| 2017-06-30 | $14M | 107k | 128.87 |
| 2017-03-31 | $13M | 115k | 109.35 |
| 2016-12-31 | $9.0M | 123k | 73.67 |
| 2016-09-30 | $13M | 146k | 87.21 |
| 2016-06-30 | $12M | 143k | 86.02 |
| 2016-03-31 | $12M | 153k | 79.15 |
| 2015-12-31 | $20M | 156k | 125.83 |
More positions owned by Skandinaviska Enskilda Banken AB
View all positions for Skandinaviska Enskilda Banken AB
Top funds holding Vertex Pharmaceuticals Incorporated
View all funds holding Vertex Pharmaceuticals Incorporated